Additional file 1 of Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer

Additional file 1: Table S1. Clinical characteristics of prostate cancer patients. Table S2. Genes involved in the 92 immune contexture-related signatures in the study. Table S3. Identified signatures correlated with BCRFS in meta-analysis of training cohorts. Table S4. Multicollinearity test used by variance inflation factors (VIF) and kappa test for selected signatures in all cohorts. Table S5. The C-index and AUC value of training and validation cohort. Table S6. Comparison of the TICS and other prognostic signatures. Table S7. GSEA results of the KEGG pathways in the high- and low-TICS groups in TCGA cohort.